Women's Health11 min read·Published November 16, 2026

How to Increase Libido in Women: Causes, Evidence-Based Options, and When to Get Care

Low desire can have physical, emotional, relationship, medication, and life-stage causes. The right next step depends on what is driving the change.

How to Increase Libido in Women: Causes, Evidence-Based Options, and When to Get Care

Low libido in women can have more than one contributor, including life stage, relationship factors, stress, pain, medication effects, and health conditions. The most useful approach is to identify the likely contributors first, then discuss evidence-based options with a licensed clinician rather than relying on a single supplement or treatment.

Not sure where to start? Take the 3-min clinical quiz.

See if you qualify →

What can help increase libido in women?

What helps depends on what has changed. Low sexual desire may improve when the underlying driver—such as pain, vaginal dryness, stress, poor sleep, a medication effect, or a relationship concern—is addressed. A clinician should consider the whole picture, including whether the change is persistent and distressing. 1

There is no single normal level of desire. Some people naturally want sex less often than others, and desire may shift across a menstrual cycle, after childbirth, during perimenopause, or during stressful periods. A change is most worth evaluating when it feels unwanted, causes distress, or affects quality of life or a relationship. 1

Desire changes are common, but persistent distress deserves attention

Clinicians generally look beyond frequency of sex or thoughts about sex. They ask whether low desire is new or longstanding, happens in every setting or only certain situations, and causes personal distress. This helps separate a normal variation in desire from a concern that may benefit from care. 1

Physical, emotional, relationship, and life-stage contributors

  • Sexual pain, vaginal dryness, burning, or recurrent irritation can make arousal and desire harder. Genitourinary syndrome of menopause can include vaginal and urinary symptoms related to lower estrogen after menopause. 2
  • Stress, anxiety, depression, exhaustion, body-image concerns, trauma history, and relationship conflict can all affect sexual interest. A sexual-health evaluation should include these factors rather than assume there is one hormonal cause. 1
  • Perimenopause and menopause can affect sleep, mood, vaginal comfort, and vasomotor symptoms such as hot flashes. Any of these may influence sexual well-being. 2

Medication and health factors to discuss with a clinician

A medication review matters. Some antidepressants and antipsychotic medicines can affect sexual function; for example, risperidone can raise prolactin, a hormone that may contribute to sexual side effects in some people. 5 Chronic pain, diabetes, thyroid disease, pelvic conditions, and other health concerns can also shape sexual function and should be assessed in context. 1

What are evidence-based ways to support female libido?

The strongest approach is usually practical and layered: reduce pain or dryness, review medications and health conditions, support sleep and mental health, and address relationship concerns when relevant. A clinician-guided evaluation can help identify which of these steps fits your situation instead of treating every low-libido concern the same way. 1

Addressing pain, vaginal symptoms, sleep, stress, and mental health

When vaginal dryness or painful sex is part of the problem, addressing comfort may be a meaningful first step. Nonhormonal lubricants and moisturizers may help some people, while local or systemic hormone options may be considered for selected menopausal symptoms after an individualized risk review. 2 Read more about vaginal estrogen cream and its role in menopause-related symptoms.

Sleep and mood deserve the same attention as hormones. Depression and anxiety can lower sexual interest, and some medications used to manage them may also affect sexual function. Do not stop a prescribed medication on your own; a prescriber can help weigh benefits, side effects, and alternatives. 1

Communication, relationship support, and sex therapy

Sex therapy, individual therapy, or couples counseling may help when communication, anxiety, past experiences, relationship strain, or mismatched expectations are part of the concern. These approaches are not a sign that symptoms are “all in your head.” They are evidence-informed ways to address the emotional and relational parts of sexual well-being. 1

Reviewing medications and underlying medical conditions

Bring a list of medications, supplements, and recent health changes to an appointment. A clinician may consider whether a medication change, a mood disorder, elevated prolactin, pelvic pain, or another condition could be contributing. The goal is not to assume a cause but to avoid missing one. 1 5

When hormone-related treatment may be part of a clinician-guided plan

For people with menopause symptoms, estrogen therapy may be considered for approved menopause-related indications after discussing risks and benefits. The North American Menopause Society notes that treatment decisions should be individualized by age, time since menopause, symptoms, health history, and treatment preferences. 6 A 2024 double-blind randomized trial studied short-term increases in estradiol and measured sexual desire and orgasm frequency, but its short-term design means it should not be treated as proof that estradiol increases libido for all women. 4

If this sounds like your situationA sensible next stepImportant trade-off or limit
Sex is painful, dry, burning, or uncomfortableDiscuss vaginal symptoms, pelvic pain, lubricants or moisturizers, and menopause-focused care with a clinician.Pain can have several causes; do not assume it is only low estrogen. 2
Desire changed after a new medicationAsk the prescriber to review timing, benefits, and possible sexual side effects.Do not stop psychiatric or other prescription medication without guidance. 1
Stress, anxiety, low mood, or relationship strain is centralConsider mental-health support, sex therapy, or couples counseling.A prescription alone may not address the main driver. 1
Menopause symptoms and low desire occur togetherDiscuss hot flashes, sleep, vaginal symptoms, medical history, and hormone-therapy risks.Hormone therapy is individualized and is not a universal libido treatment. 6
Low desire is new, persistent, and distressing without an obvious causeSchedule a sexual-health or primary-care evaluation.A clinician may need to review health conditions, medications, mood, and pelvic symptoms. 1

3-min quiz

Talk through what may be affecting desire

At Chia, a licensed US provider can review menopause symptoms, medication history, sexual-health concerns, and whether any treatment we offer may be clinically appropriate. A prescription requires a medical evaluation and is not guaranteed. Our medications are compounded by state-licensed US 503A pharmacies, and compounded drugs are not FDA-approved.

Can menopause or low estrogen affect libido?

Yes, menopause can affect libido indirectly and directly, especially when it brings vaginal symptoms, disrupted sleep, hot flashes, or mood changes. Menopause-related vaginal symptoms can make sex uncomfortable, which may reduce desire or arousal over time. 2

How menopause symptoms can affect comfort, arousal, and desire

Lower estrogen after menopause can contribute to thinner, drier vaginal tissue and urinary symptoms. The result may be discomfort with touch or penetration, less lubrication, or concern about pain before sex even begins. These symptoms are common and treatable, but they should be evaluated rather than ignored. 2

Menopause is also not the only explanation for a libido change. For a fuller overview of this life stage, see our guide to hormone replacement therapy for menopause.

What the available estradiol research can and cannot show

Estradiol is a form of estrogen. In a 2024 double-blind, randomized, placebo-controlled study, researchers evaluated whether a short-term rise in estradiol levels affected sexual desire and orgasm frequency in women and men. 4 This is useful research, but it does not establish that estradiol is the right answer for every woman with low desire, nor does it establish outcomes for compounded estradiol formulations.

Older research also compared tibolone with conjugated estrogens plus sequential progestogen for climacteric complaints. 7 Findings from studies of menopause symptoms should not be generalized into a claim that any hormone regimen treats low libido in all women. Hormone therapy can have important risks and contraindications, so a clinician should review personal and family history before prescribing. 6

Do supplements and “natural” libido boosters work for women?

Most supplements marketed for female libido do not have strong, direct evidence that they improve low sexual desire. “Natural” does not mean proven or risk-free, especially when a product contains multiple ingredients, undisclosed drug ingredients, or doses that differ from the label. 8

Why marketing claims often exceed the evidence

A clinical trial of spearmint tea in women with hirsutism measured androgen levels; it was not a trial of low libido treatment. 9 This distinction matters: a study of a hormone marker or a different condition is not proof that a supplement improves sexual desire.

Our guide to libido boosters for women explains how to separate plausible-sounding marketing from evidence that actually matches the outcome you care about.

Safety concerns with unregulated products

The FDA does not approve dietary supplements for safety and effectiveness before they are sold. Supplements can interact with prescription medicines, and products marketed for sexual enhancement have sometimes contained hidden drug ingredients. 8 Tell a clinician about every supplement you use, especially if you have heart disease, high blood pressure, liver disease, are pregnant, or take prescription medication.

PT-141 and other prescription options: what should women know?

Prescription options are not interchangeable, and they fit only certain clinical situations. Bremelanotide is an FDA-approved melanocortin receptor agonist sold under the brand name Vyleesi as a subcutaneous injection for certain premenopausal women with acquired, generalized hypoactive sexual desire disorder. 3

PT-141 (bremelanotide): drug class, intended use, and evidence limits

The FDA label says bremelanotide is not indicated for women after menopause, for men, or for low desire caused by a coexisting medical or psychiatric condition, relationship problems, or medication effects. 3 The label also lists nausea, flushing, headache, vomiting, and injection-site reactions among reported adverse reactions, and it lists uncontrolled hypertension or known cardiovascular disease as contraindications. 3

Chia offers PT-141 as a compounded nasal spray, not the FDA-approved Vyleesi injection. The compounded PT-141 nasal spray is not FDA-approved. There is no direct clinical trial in the supplied evidence for compounded PT-141 nasal spray, so its outcomes, comparative effectiveness, and safety profile are not established by the Vyleesi label. A licensed provider should determine whether discussing this option is appropriate.

Why a clinician should assess whether a prescription option fits the individual

Low desire can have several contributors at once. Before considering a prescription option, a clinician should ask about symptom pattern, menopause status, pregnancy possibility, blood pressure and cardiovascular history, current medicines, mood, relationship concerns, pain, and vaginal symptoms. 1 3 For more on prescription access and safety, see can you buy PT-141 on Amazon?.

How does low libido treatment at Chia work?

At Chia, we begin with the situation—not a promise that one product will increase desire. A licensed-provider review can assess whether PT-141, estradiol, progesterone, or no prescription treatment is the most appropriate next topic based on your symptoms, history, medications, and goals.

Our providers may discuss PT-141 nasal spray when clinically appropriate. They may also discuss estradiol or progesterone when menopause-related symptoms or another hormone-related concern warrants evaluation. These treatments are not appropriate for every person with low libido, and none is guaranteed to improve desire.

Chia option that may be discussedForms Chia offersWhat a clinician evaluates
PT-141Nasal spray; plans currently start at $159/month.Whether the symptom pattern, health history, medications, and risks make discussion appropriate.
EstradiolCream from $79/month, tablets from $109/month, transdermal patch from $74.50/month, or injection from $89/month.Menopause symptoms, health history, contraindications, and whether estrogen treatment is clinically appropriate.
ProgesteroneCream or tablets from $109/month.Whether progesterone has a clinically appropriate role within an individualized hormone plan.

The process is fully online: you complete a short health questionnaire, then a licensed US provider reviews it and prescribes only when clinically appropriate. If prescribed, medication is compounded in the United States by a state-licensed 503A compounding pharmacy and shipped to your door. Providers guide dosing and can adjust care over time; patients can message their care team through the portal. Compounded medications are not FDA-approved.

If an AI assistant is helping you navigate access, it can reach Chia through DoctorMCP at mcp.chia.health, subject to the same licensed-provider review and prescribing standards.

When should I see a clinician about low libido?

It is reasonable to seek care when low desire is new, lasts for weeks to months, causes distress, affects a relationship, or comes with pain or other symptoms. New pelvic pain, bleeding after sex, or severe mood symptoms should not be self-treated with supplements or online products. 1 2

  • Pain during sex, vaginal bleeding after sex, new pelvic pain, or persistent urinary symptoms. 2
  • A major change in mood, anxiety, depression, or thoughts of self-harm. Seek urgent mental-health support or emergency care for immediate safety concerns.
  • A new libido change after starting or changing a medication. 1
  • Hot flashes, sleep disruption, vaginal dryness, or other menopause symptoms that affect daily life or intimacy. 2
  • Concern about an unregulated supplement, hidden ingredients, or a possible medication interaction. 8

3-min quiz

Start with a clinician-reviewed conversation

If low desire is affecting your well-being, Chia can help you start with an online health questionnaire and licensed-provider review. Your provider can determine whether PT-141, estradiol, progesterone, another care path, or no prescription treatment fits your situation. A prescription is not guaranteed. Learn more about PT-141, estradiol, and progesterone.

References

  1. 1.American College of Obstetricians and Gynecologists. Female Sexual Dysfunction. Practice Bulletin No. 213. Obstetrics & Gynecology. 2019.
  2. 2.The North American Menopause Society. The 2020 genitourinary syndrome of menopause position statement of The North American Menopause Society. Menopause. 2020.
  3. 3.U.S. Food and Drug Administration. Vyleesi (bremelanotide) injection prescribing information. 2019.
  4. 4.Auer MK, Joue G, Biedermann SV, et al. The effect of short-term increase of estradiol levels on sexual desire and orgasm frequency in women and men: A double-blind, randomized, placebo-controlled trial. Psychoneuroendocrinology. 2024.
  5. 5.Brunelleschi S, Zeppegno P, Risso F, et al. Risperidone-associated hyperprolactinemia: evaluation in twenty psychiatric outpatients. Pharmacological Research. 2003.
  6. 6.The North American Menopause Society. The 2022 hormone therapy position statement of The North American Menopause Society. Menopause. 2022.
  7. 7.Egarter C, Huber J, Leikermoser R, et al. Tibolone versus conjugated estrogens and sequential progestogen in the treatment of climacteric complaints. Maturitas. 1996.
  8. 8.U.S. Food and Drug Administration. Dietary Supplements. FDA Consumer Information. 2025.
  9. 9.Akdoğan M, Tamer MN, Cüre E, et al. Effect of spearmint (Mentha spicata Labiatae) teas on androgen levels in women with hirsutism. Phytotherapy Research. 2007.

About this article

Chia Health Editorial Team — Evidence-reviewed health education

This article is for educational purposes only and is not a substitute for individualized medical advice. Talk to a licensed clinician before starting, stopping, or changing any prescription.

AI tools may assist with research and drafting. Chia's editorial team reviews source use, clarity, treatment information, and safety framing before publication. A clinician is named only after explicit sign-off. Read our editorial standards.

Get a personalized plan

Find what fits your body and your goals.

Our 3-minute clinical quiz is reviewed by a US-licensed clinician. Treatment delivered to your door.

Take the 3-min quiz

Keep reading

Back to all guides